Activating interactions of sulfanilamides with T cell receptors

Home > Journals > Medicine & Healthcare >OJI

ISSN Print: 2162-450X
ISSN Online: 2162-4526

Website: https://www.scirp.org/journal/oji
E-mail: oji@scirp.org

Citations h5-index & Ranking*

Submission

"Activating interactions of sulfanilamides with T cell receptors"
written by Stephan Watkins, Werner J. Pichler,
published by Open Journal of Immunology, Vol.3 No.3, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Immune pathomechanism and classification of drug hypersensitivity
	2019

[2]	Diagnóstico, Monitorización Y Tratamiento Inmunológico de Las Enfermedades Alérgicas: Sociedad Española de Inmunología
	2018

[3]	Drug allergy: Pathogenesis
	2018

[4]	A Practical Approach to Demystifying Drug Allergy in the Intensive Care Unit. A Review Article
	2018

[5]	Новая концепция механизмов развития лекарственной гиперчувствительности
	2017

[6]	T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance
	Asia Pacific Allergy, 2016

[7]	Mecanismos imunopatológicos das reações de hipersensibilidade a fármacos
	2016

[8]	Classification of Drug Hypersensitivity into Allergic, pi, and Pseudo-Allergic Forms
	International archives of allergy and immunology, 2016

[9]	Immunopathological mechanisms of drug hypersensitivity reactions
	2016

[10]	Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors
	International archives of allergy and immunology, 2015

[11]	Interaction of small molecules with specific immune receptors: the pi concept and its consequences
	Current Immunology Reviews, 2014

[12]	Consequences of drug binding to immune receptors: Immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for antigen or human leukocyte antigen) with altered peptide-human leukocyte antigen or peptide
	Dermatologica Sinica, 2013

[13]	Dermatologica Sinica
	NULL 2013

[14]	T cell receptor variable β20-1 harbors a nucleotide binding pocket in the CDR2β loop
	Open Journal of Immunology, 2013

[15]	T cell receptor variable [beta] 20-1 harbors a nucleotide binding pocket in the CDR2 [beta] loop
	Open Journal of Immunology, 2013

[16]	Consequences of drug binding to immune receptors: immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for …
	Dermatologica Sinica, 2013

[1]	Immune pathomechanism and classification of drug hypersensitivity Allergy, 2019 DOI:10.1111/all.13765

[2]	Multiple Drug Hypersensitivity International Archives of Allergy and Immunology, 2017 DOI:10.1159/000458725

[3]	T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance Asia Pacific Allergy, 2016 DOI:10.5415/apallergy.2016.6.2.77

[4]	Consequences of drug binding to immune receptors: Immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for antigen or human leukocyte antigen) with altered peptide-human leukocyte antigen or peptide Dermatologica Sinica, 2013 DOI:10.1016/j.dsi.2013.09.005

[5]	T cell receptor variable β20-1 harbors a nucleotide binding pocket in the CDR2β loop Open Journal of Immunology, 2013 DOI:10.4236/oji.2013.33021